Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus

Journal of Neurosciences in Rural Practice- India

doi 10.4103/jnrp.jnrp_449_17

Full Text

Abstract

Available in

Categories

Date

April 1, 2018

Authors

Naresh Mullaguri

Madihah Hepburn

Christopher Ryan Newey

Premkumar Chandrasekharan Nattanmai

Publisher

Georg Thieme Verlag KG

Related search

Reversible Cerebral Vasoconstriction Syndrome

Neurology India

English

Steroid-Responsive Reversible Cerebral Vasoconstriction Syndrome

Journal of the Korean Neurological Association

English

Reversible Cerebral Vasoconstriction Syndrome With Reversible Renal Artery Stenosis

English

Coexisting Vascular Lesions in Reversible Cerebral Vasoconstriction Syndrome

Dutch

Reversible Cerebral Vasoconstriction Syndrome After Heart Transplantation

Journal of the Korean Neurological Association

Danish

Acute Reversible Cerebral Vasoconstriction Syndrome With Low-Dose Dihydroergotamine Possibly Potentiated by Valproic Acid and Erenumab: A Case Report

Journal of Neurology Research

English

Reversible Cerebral Vasoconstriction Syndrome Associated With Coronary Artery Vasospasm

Texas Heart Institute Journal

Cardiovascular Medicine

English

Reply to “Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone”

Neurocritical Care

Intensive Care Medicine

English

Reversible Cerebral Vasoconstriction Syndrome (RCVS): A Transient Condition Being Underdiagnosed?

BMJ Case Reports

English